Antipruritic Effect of Topical Ketamine, Amitriptyline, and Lidocaine

NCT03096444 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
13
Enrollment
OTHER
Sponsor class

Stopped Efficacy was not seen after interim analysis

Conditions

Interventions

Sponsor

Gil Yosipovitch